From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine.

Giovanni Grasso, Davide Bolignano, Grasso, Alessio Sturiale, Giacobbe, Aloisi, Alessandro Allegra, Michele Buemi, Frisina, Romeo, Nostro, Alberto Romeo

Risultato della ricerca: Article

8 Citazioni (Scopus)

Abstract

Erythropoietin (EPO), already known as the stimulating hormone for erythropoiesis, has shown different and interesting pleiotropic actions. It does not only affect erythroid cells, but also myeloid cells, lymphocytes and megakaryocytes. This hormone can also enhance phagocytic function of the polymorphonuclear cells and reduce the activation of macrophages, thus modulating the inflammatory process.Moreover, hematopoietic and endothelial cells probably have the same cellular origin, and the discovery of erythropoietin receptors (EPO-R) also on mesangial and myocardial cells, smooth muscle fibrocells and neurons has prompted the study of the non-erythropoietic functions of this hormone.The interaction between EPO and VEGF may be of particular importance in neovascularization and wound healing.Different studies have demonstrated that EPO has an important direct hemodynamic and vasoactive action, which does not depend exclusively on any increase in hematocrit and viscosity. Moreover EPO showed protective effects on myocardial cells against apoptosis induced by ischemia/repefusion injury, but it could negatively affect pulmonary hypertension in patient with chronic cor pulmonale.This review aims to stress the importance of the increasing interest in EPO applications and the necessity of further studies to gain a deeper knowledge of this hormone and its pleiotropic and complex actions. © 2006 Bentham Science Publishers Ltd.
Lingua originaleEnglish
pagine (da-a)299-311
RivistaCARDIOVASCULAR & HEMATOLOGICAL AGENTS IN MEDICINAL CHEMISTRY
Volume4
Stato di pubblicazionePublished - 2006

Fingerprint

Internal Medicine
Erythropoietin
Oxygen
Hormones
Erythropoietin Receptors
Pulmonary Heart Disease
Erythroid Cells
Mesangial Cells
Megakaryocytes
Macrophage Activation
Erythropoiesis
Myeloid Cells
Hematocrit
Pulmonary Hypertension
Viscosity
Wound Healing
Vascular Endothelial Growth Factor A
Smooth Muscle
Ischemia
Endothelial Cells

All Science Journal Classification (ASJC) codes

  • Hematology
  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cita questo

From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine. / Grasso, Giovanni; Bolignano, Davide; Grasso; Sturiale, Alessio; Giacobbe; Aloisi; Allegra, Alessandro; Buemi, Michele; Frisina; Romeo; Nostro; Romeo, Alberto.

In: CARDIOVASCULAR & HEMATOLOGICAL AGENTS IN MEDICINAL CHEMISTRY, Vol. 4, 2006, pag. 299-311.

Risultato della ricerca: Article

Grasso, G, Bolignano, D, Grasso, Sturiale, A, Giacobbe, Aloisi, Allegra, A, Buemi, M, Frisina, Romeo, Nostro & Romeo, A 2006, 'From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine.', CARDIOVASCULAR & HEMATOLOGICAL AGENTS IN MEDICINAL CHEMISTRY, vol. 4, pagg. 299-311.
Grasso, Giovanni ; Bolignano, Davide ; Grasso ; Sturiale, Alessio ; Giacobbe ; Aloisi ; Allegra, Alessandro ; Buemi, Michele ; Frisina ; Romeo ; Nostro ; Romeo, Alberto. / From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine. In: CARDIOVASCULAR & HEMATOLOGICAL AGENTS IN MEDICINAL CHEMISTRY. 2006 ; Vol. 4. pagg. 299-311.
@article{b66ac8029a6445b5acb94741e575bc40,
title = "From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine.",
abstract = "Erythropoietin (EPO), already known as the stimulating hormone for erythropoiesis, has shown different and interesting pleiotropic actions. It does not only affect erythroid cells, but also myeloid cells, lymphocytes and megakaryocytes. This hormone can also enhance phagocytic function of the polymorphonuclear cells and reduce the activation of macrophages, thus modulating the inflammatory process.Moreover, hematopoietic and endothelial cells probably have the same cellular origin, and the discovery of erythropoietin receptors (EPO-R) also on mesangial and myocardial cells, smooth muscle fibrocells and neurons has prompted the study of the non-erythropoietic functions of this hormone.The interaction between EPO and VEGF may be of particular importance in neovascularization and wound healing.Different studies have demonstrated that EPO has an important direct hemodynamic and vasoactive action, which does not depend exclusively on any increase in hematocrit and viscosity. Moreover EPO showed protective effects on myocardial cells against apoptosis induced by ischemia/repefusion injury, but it could negatively affect pulmonary hypertension in patient with chronic cor pulmonale.This review aims to stress the importance of the increasing interest in EPO applications and the necessity of further studies to gain a deeper knowledge of this hormone and its pleiotropic and complex actions. {\circledC} 2006 Bentham Science Publishers Ltd.",
keywords = "Angiogenesis, Apoptosis, Cardiology and Cardiovascular Medicine, Erythropoietin (EPO), Hematology, Ischemia, Oxygen tension, Pharmacology, Pleiotropic action, Receptors",
author = "Giovanni Grasso and Davide Bolignano and Grasso and Alessio Sturiale and Giacobbe and Aloisi and Alessandro Allegra and Michele Buemi and Frisina and Romeo and Nostro and Alberto Romeo",
year = "2006",
language = "English",
volume = "4",
pages = "299--311",
journal = "CARDIOVASCULAR & HEMATOLOGICAL AGENTS IN MEDICINAL CHEMISTRY",
issn = "1871-5257",

}

TY - JOUR

T1 - From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine.

AU - Grasso, Giovanni

AU - Bolignano, Davide

AU - Grasso, null

AU - Sturiale, Alessio

AU - Giacobbe, null

AU - Aloisi, null

AU - Allegra, Alessandro

AU - Buemi, Michele

AU - Frisina, null

AU - Romeo, null

AU - Nostro, null

AU - Romeo, Alberto

PY - 2006

Y1 - 2006

N2 - Erythropoietin (EPO), already known as the stimulating hormone for erythropoiesis, has shown different and interesting pleiotropic actions. It does not only affect erythroid cells, but also myeloid cells, lymphocytes and megakaryocytes. This hormone can also enhance phagocytic function of the polymorphonuclear cells and reduce the activation of macrophages, thus modulating the inflammatory process.Moreover, hematopoietic and endothelial cells probably have the same cellular origin, and the discovery of erythropoietin receptors (EPO-R) also on mesangial and myocardial cells, smooth muscle fibrocells and neurons has prompted the study of the non-erythropoietic functions of this hormone.The interaction between EPO and VEGF may be of particular importance in neovascularization and wound healing.Different studies have demonstrated that EPO has an important direct hemodynamic and vasoactive action, which does not depend exclusively on any increase in hematocrit and viscosity. Moreover EPO showed protective effects on myocardial cells against apoptosis induced by ischemia/repefusion injury, but it could negatively affect pulmonary hypertension in patient with chronic cor pulmonale.This review aims to stress the importance of the increasing interest in EPO applications and the necessity of further studies to gain a deeper knowledge of this hormone and its pleiotropic and complex actions. © 2006 Bentham Science Publishers Ltd.

AB - Erythropoietin (EPO), already known as the stimulating hormone for erythropoiesis, has shown different and interesting pleiotropic actions. It does not only affect erythroid cells, but also myeloid cells, lymphocytes and megakaryocytes. This hormone can also enhance phagocytic function of the polymorphonuclear cells and reduce the activation of macrophages, thus modulating the inflammatory process.Moreover, hematopoietic and endothelial cells probably have the same cellular origin, and the discovery of erythropoietin receptors (EPO-R) also on mesangial and myocardial cells, smooth muscle fibrocells and neurons has prompted the study of the non-erythropoietic functions of this hormone.The interaction between EPO and VEGF may be of particular importance in neovascularization and wound healing.Different studies have demonstrated that EPO has an important direct hemodynamic and vasoactive action, which does not depend exclusively on any increase in hematocrit and viscosity. Moreover EPO showed protective effects on myocardial cells against apoptosis induced by ischemia/repefusion injury, but it could negatively affect pulmonary hypertension in patient with chronic cor pulmonale.This review aims to stress the importance of the increasing interest in EPO applications and the necessity of further studies to gain a deeper knowledge of this hormone and its pleiotropic and complex actions. © 2006 Bentham Science Publishers Ltd.

KW - Angiogenesis

KW - Apoptosis

KW - Cardiology and Cardiovascular Medicine

KW - Erythropoietin (EPO)

KW - Hematology

KW - Ischemia

KW - Oxygen tension

KW - Pharmacology

KW - Pleiotropic action

KW - Receptors

UR - http://hdl.handle.net/10447/18461

UR - http://www.ingentaconnect.com/content/ben/chamc/2006/00000004/00000004/art00003

M3 - Article

VL - 4

SP - 299

EP - 311

JO - CARDIOVASCULAR & HEMATOLOGICAL AGENTS IN MEDICINAL CHEMISTRY

JF - CARDIOVASCULAR & HEMATOLOGICAL AGENTS IN MEDICINAL CHEMISTRY

SN - 1871-5257

ER -